全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Prediction of Lung Cancer Stage Using Tumor Gene Expression Data

DOI: 10.4236/jct.2024.158028, PP. 287-302

Keywords: Lung Cancer Detection, Stage Prediction, Gene Expression Data, Xgboost, Machine Learning

Full-Text   Cite this paper   Add to My Lib

Abstract:

Lung cancer remains a significant global health challenge and identifying lung cancer at an early stage is essential for enhancing patient outcomes. The study focuses on developing and optimizing gene expression-based models for classifying cancer types using machine learning techniques. By applying Log2 normalization to gene expression data and conducting Wilcoxon rank sum tests, the researchers employed various classifiers and Incremental Feature Selection (IFS) strategies. The study culminated in two optimized models using the XGBoost classifier, comprising 10 and 74 genes respectively. The 10-gene model, due to its simplicity, is proposed for easier clinical implementation, whereas the 74-gene model exhibited superior performance in terms of Specificity, AUC (Area Under the Curve), and Precision. These models were evaluated based on their sensitivity, AUC, and specificity, aiming to achieve high sensitivity and AUC while maintaining reasonable specificity.

References

[1]  Ning, J., Ge, T., Jiang, M., Jia, K., Wang, L., Li, W., et al. (2021) Early Diagnosis of Lung Cancer: Which Is the Optimal Choice? Aging, 13, 6214-6227.
https://doi.org/10.18632/aging.202504
[2]  Chen, X., Guo, J. and Guo, M. (2020) Advances in the Treatment of Advanced Non-Small Cell Lung Cancer. Advances in Lung Cancer, 9, 30-40.
https://doi.org/10.4236/alc.2020.92004
[3]  Field, J.K., et al. (2013) Screening and Early Detection of Lung Cancer. Cancer Prevention Research, 6, 4-7.
https://cancerpreventionresearch.aacrjournals.org/content/6/1/4
[4]  Ettinger, D.S., et al. (2017) NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 4.2016. Journal of the National Comprehensive Cancer Network, 15, 504-535.
https://jnccn.org/view/journals/jnccn/15/4/article-p504.xml
[5]  Hirsch, F.R., et al. (2017) Lung Cancer: Current Therapies and New Targeted Treatments. The Lancet, 389, 299-311.
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(16)30958-8/fulltext
[6]  Goldstraw, P., et al. (2016) The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer. Journal of Thoracic Oncology, 11, 39-51.
https://www.jto.org/article/S1556-0864(15)33615-1/fulltext
[7]  Shedden, K., et al. (2008) Gene Expression-Based Survival Prediction in Lung Adenocarcinoma: A Multi-Site, Blinded Validation Study. Nature Medicine, 14, 822-827.
https://www.nature.com/articles/nm.1790
[8]  Kratz, J.R., et al. (2012) A Practical Molecular Assay to Predict Survival in Resected Non-Squamous, Non-Small-Cell Lung Cancer: Development and International Validation Studies. The Lancet, 379, 823-832.
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(11)61941-7/fulltext
[9]  Chen, H.-Y., Yu, S.-L., Chen, C.-H., Chang, G.-C., Chen, C.-Y., Yuan, A., et al. (2007) A Five-Gene Signature and Clinical Outcome in Non-Small-Cell Lung Cancer. New England Journal of Medicine, 356, 11-20.
https://www.nejm.org/doi/full/10.1056/NEJMoa060096
[10]  Roepman, P., et al. (2009) An Immune Response Enriched 72-Gene Prognostic Profile for Early-Stage Non-Small-Cell Lung Cancer. Clinical Cancer Research, 15, 284-290.
https://clincancerres.aacrjournals.org/content/15/1/284

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133